CAP protocol 2

chemotherapy protocol consisting of above compounds; used in the treatment of breast, lung, ovarian cancer & leukemia

Also Known As:

CAP combination

Networked: 14 relevant articles (2 outcomes, 6 trials/studies)

Relationship Network

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - CAP protocol 2: 14
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - CAP protocol 2: 14
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - CAP protocol 2: 14
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthacenes
        Anthracyclines: 9423
        Daunorubicin: 2641
        Doxorubicin: 35390
        CAP protocol 2: 14
  - Halogenated Hydrocarbons: 42
    - Mustard Compounds: 3
      - Nitrogen Mustard Compounds: 2
        Melphalan: 4353
        Peptichemio: 59
        CAP protocol 2: 14
        Phosphoramide Mustards: 5
        Cyclophosphamide: 25473
        CAP protocol 2: 14
- Organophosphorus Compounds: 300
  - Phosphoramides: 8
    - Phosphoramide Mustards: 5
      - Cyclophosphamide: 25473
        CAP protocol 2: 14
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthacenes
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390
        CAP protocol 2: 14
Carbohydrates: 22023
- Glycosides: 2119
  - Aminoglycosides: 5131
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390
        CAP protocol 2: 14
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - Peptichemio: 59
      - CAP protocol 2: 14

Experts

1.	Jiang, Yi: 1 article (11/2019)
2.	Li, Guilian: 1 article (11/2019)
3.	Li, Machao: 1 article (11/2019)
4.	Liu, Haican: 1 article (11/2019)
5.	Liu, Zhiguang: 1 article (11/2019)
6.	Wan, Kanglin: 1 article (11/2019)
7.	Wang, Ruibai: 1 article (11/2019)
8.	Xu, Donglei: 1 article (11/2019)
9.	Xu, Zhengquan: 1 article (11/2019)
10.	Zhao, Li-Li: 1 article (11/2019)

Related Diseases

1.	Neoplasms (Cancer) 01/20/1989 - "CAP combination chemotherapy seemed to be effective for the treatment of tubal cancer and further study with more cases is warranted." 11/01/1990 - "The patient was treated with CAP combination therapy following resection of the tumor; however, an intraperitoneal recurrence probably due to implantation was recognized 11 months later." 01/01/1985 - "The analysis of the in vitro-in vivo correlation showed that in case of in vitro resistance against two components of the CAP combination the tumor progressed during CAP treatment. "
2.	Ovarian Neoplasms (Ovarian Cancer) 04/01/1989 - "The results indicated that a CAP combination had improved the survival rate of ovarian cancer, and statistically significant differences were proved. "
3.	Breast Neoplasms (Breast Cancer) 04/30/1985 - "Results of this controlled trial showed the advantage of the CAP combination chemotherapy in the treatment of metastatic breast cancer." 01/01/1984 - "The preliminary results of this controlled trial show the advantage of the CAP combination in the treatment of metastatic breast cancer." 06/01/2015 - "LAP/CAP combination therapy may be an effective treatment option for brain metastases of HER2-positive breast cancer in which TZB essentially has no effect." 04/30/1985 - "Cyclophosphamide, adriamycin and platinum (CAP) combination chemotherapy, a new effective approach in the treatment of disseminated breast cancer. "
4.	Carcinoma (Carcinomatosis) 04/01/1984 - "Sixty patients with advanced squamous cell lung carcinoma were entered in a study comparing the effectiveness of BACON and CAP combination chemotherapy. " 01/01/1984 - "Fourteen patients with advanced carcinoma of the breast were treated with CAP combination therapy. " 04/01/1984 - "This study seems to indicate a role for the CAP combination (cyclophosphamide, adriamycin, cisplatinum) as treatment for patients with squamous cell lung carcinoma."
5.	Adrenocortical Carcinoma 04/01/1983 - "Eleven patients with advanced progressive metastatic adrenal cortical carcinoma, for whom no further standard therapy was available, were entered into a phase II study of cyclophosphamide, doxorubicin, and cisplatin (CAP) combination chemotherapy. "

Related Drugs and Biologics

1.	Doxorubicin (Adriamycin)
2.	Cyclophosphamide (Cytoxan)
3.	Cisplatin (Platino)
4.	beta-Lactams
5.	Fluoroquinolones
6.	Macrolides
7.	Platinum
8.	Anti-Bacterial Agents (Antibiotics)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Therapeutics
3.	Craniotomy